NCT03531840 2021-04-09Olaparib in People With Malignant MesotheliomaNational Institutes of Health Clinical Center (CC)Phase 2 Completed23 enrolled 16 charts
NCT02430311 2019-07-31The Pharmacokinetics and Safety of Olaparib Alone and With Paclitaxel in Chinese Patients With Advanced Solid Tumour.AstraZenecaPhase 1 Completed36 enrolled 24 charts